Yuyu Pharma Inc (000227.KS)
Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.
Company Info
Highlights
₩37.62B
₩99.74B
₩37.62B
₩8,915.94 - ₩12,539.58
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Yuyu Pharma Inc (000227.KS) returned 8.04% year-to-date (YTD) and -8.45% over the past 12 months. Over the past 10 years, 000227.KS returned 7.71% annually, underperforming the S&P 500 benchmark at 10.85%.
000227.KS
8.04%
-1.15%
7.62%
-8.45%
-22.06%
0.60%
7.71%
^GSPC (Benchmark)
0.51%
3.96%
-2.00%
12.02%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of 000227.KS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0.63% | -0.21% | -1.04% | 9.98% | -1.15% | 8.04% | |||||||
| 2024 | -0.65% | 4.10% | -8.82% | -3.80% | 2.78% | -1.75% | 3.11% | -3.88% | -6.10% | -3.92% | -3.18% | -0.38% | -20.99% |
| 2023 | 7.57% | -5.81% | -6.49% | -1.40% | -3.84% | -6.14% | -21.59% | 12.46% | 0.09% | -10.71% | 65.90% | -25.98% | -18.41% |
| 2022 | -1.11% | 11.80% | 3.02% | -4.88% | 14.36% | -25.78% | 6.04% | -5.41% | -12.35% | -0.34% | 3.79% | 0.72% | -15.78% |
| 2021 | -12.91% | -1.21% | 54.97% | 32.88% | -4.24% | 0.88% | -8.42% | -10.15% | -2.35% | 4.37% | -35.15% | 16.81% | 8.74% |
| 2020 | -1.86% | -4.07% | -7.91% | 15.64% | 10.08% | 9.40% | 98.24% | 2.89% | -23.43% | -3.24% | -4.08% | 1.89% | 78.31% |
| 2019 | 8.99% | -3.19% | 0.82% | 9.54% | -3.48% | -1.29% | -3.66% | -4.34% | 6.52% | 5.32% | -5.05% | 1.17% | 10.27% |
| 2018 | 4.02% | -1.03% | 7.55% | -7.02% | 7.81% | -6.28% | -3.87% | -3.49% | 3.33% | -11.56% | 10.64% | -4.02% | -6.34% |
| 2017 | -2.40% | 4.51% | -2.82% | -1.23% | 24.48% | 18.33% | -17.75% | 84.93% | -25.37% | 4.96% | 5.91% | -15.86% | 53.13% |
| 2016 | 27.82% | -18.10% | 4.70% | -3.05% | -0.79% | -11.61% | -11.94% | -0.34% | -1.70% | -9.69% | -11.49% | 8.23% | -30.45% |
| 2015 | 1.04% | 15.10% | 20.59% | 7.23% | -3.12% | 40.19% | 31.85% | 17.13% | -6.24% | -5.63% | -8.94% | 8.04% | 174.59% |
| 2014 | 6.49% | 2.64% | 13.37% | -6.28% | 2.49% | 5.47% | -1.15% | 11.52% | -8.50% | -4.57% | -1.50% | 2.58% | 22.10% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 000227.KS is 39, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Yuyu Pharma Inc (000227.KS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Yuyu Pharma Inc provided a 1.16% dividend yield over the last twelve months, with an annual payout of ₩120.00 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₩120.00 | ₩120.00 | ₩0.00 | ₩110.00 | ₩110.00 | ₩110.00 | ₩110.00 | ₩105.00 | ₩195.00 | ₩95.00 | ₩95.00 | ₩95.00 |
Dividend yield | 1.16% | 1.25% | 0.00% | 0.73% | 0.61% | 0.66% | 1.17% | 1.22% | 2.09% | 1.52% | 1.05% | 2.81% |
Monthly Dividends
The table displays the monthly dividend distributions for Yuyu Pharma Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | |||||||
| 2024 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩120.00 | ₩120.00 |
| 2023 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2022 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩110.00 | ₩110.00 |
| 2021 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩110.00 | ₩110.00 |
| 2020 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩110.00 | ₩110.00 |
| 2019 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩110.00 | ₩110.00 |
| 2018 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩105.00 | ₩105.00 |
| 2017 | ₩0.00 | ₩0.00 | ₩95.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩100.00 | ₩195.00 |
| 2016 | ₩0.00 | ₩0.00 | ₩95.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩95.00 |
| 2015 | ₩0.00 | ₩0.00 | ₩95.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩95.00 |
| 2014 | ₩95.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩95.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Yuyu Pharma Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Yuyu Pharma Inc was 87.56%, occurring on Jun 24, 2004. Recovery took 1802 trading sessions.
The current Yuyu Pharma Inc drawdown is 81.37%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -87.56% | Nov 22, 2001 | 676 | Jun 24, 2004 | 1802 | Aug 10, 2011 | 2478 |
| -83.83% | Apr 20, 2021 | 894 | Dec 9, 2024 | — | — | — |
| -72.45% | Aug 8, 2000 | 61 | Oct 31, 2000 | 272 | Nov 15, 2001 | 333 |
| -69.95% | Aug 11, 2011 | 202 | Jun 4, 2012 | 760 | Jul 3, 2015 | 962 |
| -61.77% | Aug 14, 2020 | 119 | Feb 8, 2021 | 45 | Apr 15, 2021 | 164 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Yuyu Pharma Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Yuyu Pharma Inc is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 000227.KS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 000227.KS has a P/S ratio of 0.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 000227.KS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 000227.KS has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |